| |
 |
Editorial [Hot topic: Phosphodiesterase-5 Inhibitors and their Use in the Treatment of Urological Conditions (Executive Editor: Perimenis Petros)]
|
| |
|
pp.3463-3463 (1) Author: Perimenis Petros
|
| |
|
|
| |
|
PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile
|
| |
|
pp.3464-3475 (12) Authors: D. Kouvelas, A. Goulas, G. Papazisis, C. Sardeli, C. Pourzitaki
|
| |
|
|
| |
|
Phosphodiesterase Type 5 Inhibitors: Unmet Needs
|
| |
|
pp.3476-3485 (10) Authors: K. Hatzimouratidis, D. G. Hatzichristou
|
| |
|
|
| |
|
Phosphodiesterase Type 5 Inhibitors for the Management of Erectile Dysfunction: Preference and Adherence to Treatment
|
| |
|
pp.3486-3495 (10) Authors: T. F. Al-Shaiji, G. B. Brock
|
| |
|
|
| |
|
Prophylaxis of Erectile Function After Radical Prostatectomy with Phosphodiesterase Type 5 Inhibitors
|
| |
|
pp.3496-3501 (6) Authors: F. Deho, A. Gallina, A. Salonia, A. Briganti, N. Suardi, G. Zanni, G. Guazzoni, P. Rigatti, F. Montorsi
|
| |
|
|
| |
|
PDE5 Inhibitors in the Treatment of LUTS
|
| |
|
pp.3502-3505 (4) Author: M. J. Speakman
|
| |
|
|
| |
|
Is There a Role for PDE5 Inhibitors in the Management of Male Infertility Due to Defects in Testicular or Epididymal Function?
|
| |
|
pp.3506-3520 (15) Authors: F. Dimitriadis, P. Tsounapi, M. Saito, T. Watanabe, A. Sylakos, S. Tsabalas, I. Miyagawa, N. Sofikitis
|
| |
|
|
| |
|
PDE5 Inhibitors in Non-Urological Conditions
|
| |
|
pp.3521-3539 (19) Authors: C. Vlachopoulos, D. Terentes-Printzios, N. Ioakeimidis, K. Rokkas, C. Stefanadis
|
| |
|
|
| |
|
Phosphodiesterase-5 Inhibitors: Future Perspectives
|
| |
|
pp.3540-3551 (12) Authors: Giannitsas Konstantinos, Perimenis Petros
|
| |
|
|
| |
|
Recent Advances of Fluorescent Technologies for Drug Discovery and Development
|
| |
|
pp.3552-3570 (19) Authors: Chiranjib Chakraborty, Chi-Hsin Hsu, Zhi-Hong Wen, Chan-Shing Lin
|
| |
|
|
| |
|
Role of Calcitonin Gene-Related Peptide in Gastric Mucosal Defence and Healing
|
| |
|
pp.3571-3576 (6) Author: S. Evangelista
|
| |
|
|
| |
|
Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides
|
| |
|
pp.3577-3589 (13) Authors: D. Leali, P. Alessi, D. Coltrini, M. Rusnati, L. Zetta, M. Presta
|
| |
|
|
